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Objective: To evaluate by species-specific irnmunoblots the association of Borrelia burgdorferi sensu stricto, B. garinii 
and 6. afzelii with neuroborreliosis in Switzerland. 
Methods: Borrelia strains isolated from the cerebrospinal fluid (CSF) of three children with neuroborreliosis were typed 
by phenotypic and genotypic analysis. The serologic reactions (IgG) of these three patients as well as those of 28 patients, 
including one of these three children, with confirmed neuroborreliosis were characterized and scored by imrnunoblots 
on the three individual Borrelia species antigens. Twenty patients with typical erythema migrans served as a control 
group. 
Results: Phenotypic and genotypic analysis confirmed that all three CSF isolates were B. garinii. In the 28 patients with 
neuroborreliosis, the comparatively strongest reactions were as follows: 18 to B. garinii, three to  B. burgdorferi sensu 
stricto and two to  6. afzelii; five were inconclusive. In the control group (erythema migrans), the comparatively strongest 
reactions were as follows: six B. garinii, one to 6. burgdorferisensu stricto and five to B. afzelii; eight were indeterminate. 
Conclusions: Typing of these three CSF isolates and characterization by imrnunoblots of the antibody reactions 
of patients with neuroborreliosis give additional evidence of the association of B. garinii and neuroborreliosis. Our 
serologic results suggest that B. burgdorferi sensu stricto and B. afzelii are also responsible for some neuroborreliosis 
cases in Switzerland. Our immunoblots and the scoring system proved particularly useful for the serologic typing of 
patients with late Lyme borreliosis. 
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I NTRO D U CTlO N 
Borrelia buvgdoferi was discovered and recognized as the 
causative agent of Lyme borreliosis by Burgdorfer et a1 
[l]. This spirochete is transmitted by ticks of the Ixodes 
ricinur complex. In Switzerland, up to 55% of Ixodes 
ricinur ticks are infected with B. burgdorfeeri sensu lato 
The first clinical manifestation of Lyme borreliosis 
[2-41. 
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is a distinctive skin lesion, erythema migrans (EM), 
which appears a few days to a few weeks after tick bite. 
This lesion may last from 3 days to several weeks and 
may be accompanied by fever, headache and malaise 
[5]. Patients seem to recover, but without antibiotic 
treatment some will suffer from complications such as 
neurologic disorders, cardm manifestations, or articular 
migrating pain. In some patients, chronic diseases 
may develop which may affect the skin, such as acro- 
dermatitis chronica atrophicans, a clinical manifestation 
primarily observed in Europe, or the joints with 
arthritis, which is more common in the USA [S]. 
Neurologic disease with chronic meningitis or severe 
degenerative cerebral lesions that may mimic multiple 
sclerosis may also develop. Neuroborrelioses are also 
more frequent in Europe, and differences in the clinical 
manifestations have been described compared to those 
423 
4 2 4  Cl in ica l  M i c r o b i o l o g y  and  In fec t i on ,  Volume 3 Number  4, A u g u s t  1997 
in the USA [6]. Shortly after its discovery in ticks, the 
causative agent, later named B. burgdolferi, was isolated 
from the blood and, thereafter, from the skin, cerebro- 
spinal fluid and synovial fluid of patients in many parts 
of the world [7-151. More recent genetic and pheno- 
typic analyses of B. bur&vferi isolates have revealed 
differences leading to the classification of B. buvgdolferi 
sensu stricto, B. gurinii [I61 and B. ufielii [17]. Some 
studies described correlations between each of these 
species and specific clinical manifestations of the disease: 
B. bupfovferi sensu stricto with arthritic conditions, 
B. garinii with neurologic disorders, and B. dfielii with 
the skin disorder acrodermatitis chronica atrophicans 
[ 18-20]. However, controversial reports described a 
good match between the distribution of Borreliu in ticks 
and in patients of the same area, suggesting a lack of 
organotropism [21] or organotropism linked to strain- 
specific characteristics, not to genotypes [22]. 
These three species can be readily typed by Western 
blot according to immunoreactions with monoclonal 
antibodies H3TS, specific for B. burgdolferi sensu stricto, 
D6 for B. garinii, and I 17.3 and J 8.3 for B. afielii 
[16,17,23] or by PCR restriction fragment length poly- 
morphism analysis [24]. In this study, the relation- 
ship between neuroborreliosis and three species of B. 
bcrydovferi sensu lato was investigated. The borreliae 
isolated from the cerebrospinal fluid (CSF) of three 
children with neurologic symptoms were characterized. 
The antibody responses of each patient to the three 
species of B. bqdovfer i  sensu lato and to their own 
isolate by immunoblot (Western blot) assays were 
compared. The particular antibody responses of these 
patients prompted us to look at a larger group of 
patients with confirmed neuroborreliosis. Sera from 
28 patients, including one of these three children, with 
neuroborreliosis and intrathecal antibody synthesis 
were evaluated for reactions to B. hcrvgdoferi sensu 
stricto, B. gurinii and B. afielii by immunoblot. A 
control group of 20 patients with EM was compared 
for reaction to the three species by the same method in 
order to check for the prevalence of the Borreliu species 
associated with the early stage of the disease. Patients 
from both groups came from the same geographic area, 
the western, or French-speaking, part of Switzerland. 
MATERIALS AND METHODS 
Patients for Borrelia burgdorferi sensu lato isolation 
Thirty-four CSF samples from children were cultivated 
for isolation of B. buvgdovferi sensu lato. Complete case 
reports have already been published for the three 
children with isolates [11]. In short, the first patient 
(BP), a 4-year-old boy, was admitted to the hospital of 
Visp (Valais, Switzerland) in August 1990 for left facial 
paralysis. The second patient (BM), a 7-year-old boy, 
was hospitalized in summer 1991 at the same hospital. 
He had a diplopy, accompanied by loss of balance. 
Neither of these two patients had detectable antibody 
in their CSF. The third patient (DA), a 7-year-old boy, 
was admitted in September 1991 to the University 
Hospital of Lausanne (CHUV, Vaud, Switzerland) for 
epilepsy-like-crisis, and 4 weeks later for a papillary 
edema. High antibody titers to B. buyydovferi sensu lato 
were detected in serum as well as in CSE 
CSF was centrifuged at 10 OOOg for 10 min. The 
supernatant was collected for serologic testing. The 
pellet was resuspended in a few drops of the remaining 
supernatant and cultured in 5 mL of BSK-I1 medium 
(Barbour-Stoenner-Kelly medium) [25]. Dark field 
examination of the culture was performed twice, first 
after 10 days and then after 21 days. After 3 weeks, the 
culture was centrifuged at 10 OOOg for 10 min, the 
pellet was resuspended in fresh BSK-I1 medium, and 
the culture was kept for 3-4 additional weeks. 
Preparation of antigens 
The strains of Borrelia were: B31 reference strain 
isolated from Ixodes scupuluris ( I .  dammini, Shelter Island, 
NY) (B. butgdovferi sensu stricto), VS 215 (B. buvgdovferi 
sensu stricto from I .  ricinus), VS 3, VS 302 (B.  garinii 
from I .  ricinus) and VS 461 (B. afielii from I. ricinus) [23] 
and the three isolates from the patients [ l l ] .  The 
cultures were collected during their logarithmic growth 
phase, and washed twice in phosphate-buffered saline 
(PBS) (0.1 M, pH 7.45) with added MgCI2 (5 mM). 
For the electrophoresis, the pellet was resuspended 
in distilled water. The protein concentration of the 
suspension was determined by the Biuret method, and 
adjusted to 1 mg/mL with distilled water; the sus- 
pension was then frozen until use. The isolate VS 3, 
used as antigen for the immunofluorescence assay, was 
washed first in PBS as above and then briefly in distilled 
water containing 0.05% sodium dodecylsulfate (SDS). 
The pellet was quickly resuspended in PBS containing 
5% yolk sac. 
Isolates used in this study were all low-passage 
strains (fewer than eight passages in BSK-I1 medium). 
Genetic characterization of isolates 
Isolates were identified to the species level by restriction 
enzyme analysis of rvf(5S)-rrl(23S) intergenic spacer 
amplicons as previously described [24]. Briefly, two 
oligonucleotides in the 3' end ofthe first 5 s  rRNA (rvf) 
and the 5' end of the second 23s rRNA ( rv l )  were used. 
The reaction occurred in a 50-pL reaction mixture 
containing 5 pL of bacterial thermolysate. Positive and 
negative controls were included in each reaction. The 
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PCK was carried out under the usual conditions, in an 
OniniGene thermocycler (Hybaid Limited, UK), for a 
total of 35 cycles (94°C for 1 min, annealing at 55OC 
for 1 niin and elongation at 72 "C for 1 min). Amplified 
DNA was electrophoresed through 1% agarose gel and 
visualized by ethidium bromide staining. 
PCR products were digested by the endonucleases 
A4xI (New England Biolabs, Beverly, MA, USA) 
and DruI (Amersham International, Aniersham, UK) 
according to the manufacturer's instructions. Electro- 
phoresis of restricted DNA was carried out in a 16% 
acrylaniide/0.8% bisacrylamide gel for 90 niin at  130 V. 
Restricted DNA fragments from type strains were used 
as size controls. 
Patients for serological study 
Twenty-eight sera from symptomatic patients with 
neuroborreliosis proven by intrathecal antibody syn- 
thesis (index 2.2-144, cut-off value 2) were evaluated 
for iinmunologic (IgG) reaction to the three species 
of B. b q d o t j i e r i  sensu lato. Sera from 20 patients 
with typical EM and a positive screening test ELFA 
(enzyme-linked fluorescent assay) (Vidas Lyme IgG and 
IgM bioMPrieux, France) for Bovreliu were randomly 
chosen as a control group. 
Screening tests 
The indirect microimniunofluorescence assay (IgG 
and IgM) was performed as described l~reviously [26] 
and adapted for B. bcrrgdovfevi sensu lato (isolate VS 3, 
B. gurinii). Sera were diluted starting at  32 (reciprocal 
titer) and CSF at 2. In the sera, IgG antibody titers of 
256 or more were considered as positive, as were 
antibody titers of 8 or more in the CSF. Immuno- 
globulins M and A at a titer of 32 were defined as 
positive in the absence of rheumatoid factor. The index 
of intrathecal antibody synthesis was calculated as 
follows: IgG-specific CSF/serum divided by albumin 
CSF/seruni (negative below 2.0). 
Sera were screened for antibody to B. bcrrgdotjieri 
sensii lato by ELFA VIDAS Lyme IgG and IgM 
(BioMkrieux, France). This commercial test used a 
B. bcrrgdotjivi sensu stricto strain (B31). The tests were 
performed and interpreted according to the manu- 
facturer's instructions. Relative fluorescence values 
(RFV) <0.75 were negative, 0.75-1.00 equivocal and 
>1 .OO positive. 
Electrophoresis and immunoblot 
The SDS-PAGE and immunoblot assay were per- 
formed as previously described [23]. In short, the 
suspension of washed borrelia (protein concentration 
of 1 mg/mL) was electrophoresed (constant voltage 
170 V) on a 12.5% polyacrylamide gel. The standard 
molecular weights (MW) of BioRad (low-range pro- 
tein molecular weight standards) were used as references 
for the calculation of relative molecular weights. The 
gels were either stained with Cooinassie blue or were 
transferred by Western blot to polyvinylidene fluoride 
(PVDF) membrane (Immobilon, Millipore, Kloten, 
Switzerland). 
Iinniunoreactions were performed with human 
serum diluted 1:200 or with nionoclonal antibodies 
diluted 1:500 for H3TS (Symbicon, Sweden), 1:500 000 
for I 17.3 and J 8.3 (kindly provided by G. Baranton, 
Institut Pasteur, Paris), and 1:100 for 116. Fixed anti- 
bodies were revealed by a secondary antibody (anti- 
human or antimouse IgG y chain specific or IgM p 
chain specific) conjugated to alkaline phosphatase, 
followed by the addition of substrate BCIP/NBT 
(5-bronio-4-chloro-3-indoyl-p-toluidine phosphate/ 
p-nitroblue tetrazolium chloride) (Kirkegaard and 
Perry Lab., Gaithersburg MD, USA). 
Criteria for a positive IgC immunoblot with human 
serum were a nlinimuni of five bands, including flagellin 
and two of the following specific bands: OspC, OspA, 
OspB, p39, 93 kDa (~100) .  Our criteria were almost 
identical to those of EngstrGni et a1 1271. 
Imniunoblots for IgG to local isolates belonging to 
the three species were performed with three strips, one 
for each species (VS 215, B. butgdotjieri sensu stricto; VS 
102, B. p v i n i i  and VS 461, B. afielii). They were 
prepared and incubated with the sera of individual 
patients and were processed at all steps in the same tray 
strip. 
Immunologic reactivity scoring 
For comparison between the three inimunoblots, 
scores were allocated (0-3 points) depending on the 
presence and intensity of the reaction to seven proteins 
of Bovreliu as shown in Figure 1: 93 kUa (plOO), 
flagellin, p39, OspA, OspD, OspC and 18 kUa. All but 
18 kDa proteins were first identified in the three 
Borvelia species by monoclonal antibodies: 181.1 (p93), 
H9724 (flagellin), p39, H5332 (OspA), HlCX (OspD), 
LA22 2B8 (kindly provided by A. G. Barbour, 
University of California, Irvine CA; W. T. Golde, 
CDC, Fort Collins CO; T. Schwan, Kocky Mountain 
Lab., Hamilton MT, USA; B. Wilske Max von 
Pettenkofer Institute, Miinchen, Germany). Keadings 
were performed by two independent persons. A total 
score superior by two points for one individual 
species compared with the other species was considered 
as a specific reaction (for example, B 13, A 12, G 16 
was typed as B. guvinii (Figure 1)). This criterion 
was based on the significant differences observed in 
the statistical analysis of the mean scores. Since only 
minor divergences were observed for the typing of the 
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Figure 1 Inmunoblots (IgG) with the serum of a patient 
with neuroborreliosis and reaction specific to B. garinii. 
Strip B: VS 215-B. burgdovferi sensu stricto. Strip A: VS 
461-B. uzielii. Strip G: VS 102-B. garinii. Score points 
are allocated to proteins: 93 kDa, flagellin, p39, OspA, 
OspD, OspC and 18 kDa. 
serologic reactions between the two readers, we used 
the classification of one reader only. 
Statistical analysis 
A statistics software package (Statsoft, Phoenix, 
AZ, USA) was used to analyze differences between the 
EM and neuroborreliosis groups (chi-squared test) and 
differences between individual paired reactivity scores 
for Bovvelia species (Wilcoxon matched paired test). 
RESULTS 
Isolation and characterization of Borrelia burgdorferi 
sensu lato 
Thirty-four CSF samples from children were cultivated 
and three of them provided isolates. The culture char- 
acteristics of the three isolates varied. The first isolate 
(VS BP) was obtained after 6 weeks of culture, whereas 
the isolate VS BM grew within 10 days, and the culture 
was highly positive after 7 days with the isolate VS DA. 
The protein patterns of all the isolates, as detected 
by Coornassie blue staining (Figure 2), revealed many 
identical bands, mainly above the flagellin (41 kDa). 
The electrophoretic mobility of the OspA (32.5 kDa) 
of the three human isolates was comparable to that of 
the tick isolate VS 102. Distinct protein patterns were 
observed with the three isolates. The VS DA isolate 
demonstrated a strong expression of OspC (23 kDa) 
Figure 2 Coomassie blue-stained SDS-PAGE of whole cell 
lysates of B. burgdalferi isolates. VS BP, VS BM, VS DA: 
CSF isolates. VS 102, B. garinii tick isolate; B31, B. 
buvgdoferi sensu stricto reference strain; VS 461, B. afielii 
reference strain, tick isolates. MW Molecular mass in 
kilodaltons. f=flagcllin; arrow=p39; a=OspA; b=OspB; 
c=ospc .  
and a low amount of OspA. The VS BM isolate showed 
a strong band around 66 kDa. The VS BP isolate 
expressed OspA strongly in comparison to other CSF 
isolates. The immunoreactivity of the isolates with the 
monoclonal antibody D6 (no reactions were detected 
with monoclonal antibodies H3TS and I 17.3) con- 
firmed that these three isolates belonged to the species 
B. garinii .  
PCR amplification of the spacer region between 
the two vfand rrl genes generated a fragment of about 
250 bp. The patterns produced by these isolates after 
cleavage by A4d and DruI were compared to those of 
the type strains of each of the species B. gurinii, €3. 
bcrrgdofevi sensu stricto and B. afielii (Figure 3). The 
three strains VS BP, VS BM and VS 102 exhibited the 
same pattern as the type strain 20047 of B. garini i ,  
with three fragments of 108, 95 and 50 bp (Figure 3A). 
The M e 1  pattern generated by the strain VS DA is 
slightly different, in that the fragment of 95 bp is about 
5 bp longer. However, the DruI pattern exhibited by 
this strain is indistinguishable from patterns of other B. 
pvini i  strains (Figure 3B) with these running con- 
ditions. Based on the analysis of restriction fragment 
length polymorphism of the amplified product of the 
rf-rvl spacer, the four strains were assigned to the 
species B. guvinii. 
Homologous and heterologous antibody reactions 
The first patient, BP, showed a very weak antibody 
response by immunoblot. A reciprocal titer of 64 
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Table 1 Serologic results of the seruni and 'CSF from the antibodies detectable by IFA and ELFA, and the 
three patients by enzyme-linked fluorescencc assay (ELFA), immunoblot was considered weakly positive, The 
serologic response of patient LIA was clearly positive by indirect ininiunofluorescence assay (IFA) and inimunoblot 
IFA, ELFA and inimunoblot. Specific IgG antibodies (IR) 
Pat1rnts BP HM DA were also detected in  the CSF by iiiimunoblot and by 
IFA at a titer of 256 without IgA. T h e  CSF samples of Serum 
ELFA (IgG+IgM) 0.80 1.07 5.72 
IFA IgG 64 2.56 512 
IFA IxM <32 <32 132 
I13 IgG (+) (+I +++ 
IB ISM - - - 
CSF 
IFA IgG <2 <2 256 
IFA IgA < 2  1 2  < 2  
I H  IgG - - +++ 
1B IgA - - - 
Figure 3 Restriction patterns of B. huydoferi sensu lato 
strains, after digestion of PCR products by M.wI (A) and 
DruI (B). DNA was electrophoresed on a 16% acrylamide 
gel, stained with ethidium bromide and UTi illuminated. 
Lane 1 : €3. py in i i  strain 20047 (reference strain). Lanes 2-5: 
VS BP, VS BM, VS DA (CSF isolates) and VS 102 (tick 
isolate). Lane 6 :  B. biqgdoufeyi sensu stricto main B31. 
Lane 7: B. ufirlii strain VS 461. 
Figure 4 (A) Immunoblot IgG of serum from patient BP 
using the isolates in the same order as in Figure 2. 
(B) Immunoblot IgG of serum from patient BM using the 
Same isolates. (C)  Imniunoblot IgG of serum from patient 
DA using the same isolates. 
(insignificant) was defined by the indirect immuno- 
fluorescence assay (IFA) test and ELFA results were 
equivocal (Table 1). Patient BM developed specific 
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the other two patients were negative by both tests. No 
IgM was detected by immunoblot in the sera of the 
three patients. 
We characterized the patients’ antibody responses 
by immunoblot to their own isolates and to repre- 
sentative isolates of each of the species B. bugdorfevi 
sensu stricto (€3 31), B. guvinii (VS 102) and B. afielii 
(VS 461). Patient BP (Figure 4A) demonstrated a weak 
positive antibody response to VS 102 and to B 31, with 
detectable reaction to OspC and to a 12-kDa antigen. 
The reaction to flagellin was weak with all the isolates, 
except VS BM. The serologic reaction of patient BP to 
his own isolate would be considered as negative. Patient 
BM (Figure 4B) developed a stronger antibody res- 
ponse, mostly to isolates VS 102, B 31, VS DA and 
his own isolate VS BM. Antibodies to OspC, OspA, 
p39, flagellin and the 12-kDa antigen were detectable. 
Weaker reactions were observed to VS 461 and VS BP. 
The serum of patient DA showed a strikingly high 
reactivity to isolate VS DA (Figure 4C). This patient 
also developed a stronger serologic reaction to B. garinii 
isolates than to B. buvgdorferi sensu stricto (B 31) and to 
B. ufzelii (VS 461). 
Serologic reactivity of patients with neuroborreliosis and 
with EM 
Sera from patients with neuroborreliosis or EM were 
evaluated for IgG reactivity against local tick isolates 
Table 2 Attribution of serologic reaction to one particular 
species using the criteria of a total score superior by two 
points compared with the other two Borvelia species 
No. of 
patients G B A Inc. 
Neuroborreliosis 28 18 (64%)a 3 (11%) 2 (7%)h 5 (18%) 
EM 20 6 (30%)” 1 (is) 5 (25%1)~ 8 (40%) 
”Chi-square ~ 4 . 0 2 .  
‘Chi-square p<0.01. 
G=Borrelia p i n i i ;  B=Borrelia b q d o f e r i  sensu stricto; A=Borrelia 
afielii; Inc.=inconclusive. 
belonging to the three species of B. buvgdavfevi sensu 
lato. 
The serologic responses of the 28 patients with 
confirmed neuroborreliosis gave the following total 
scores (mean of the two readers): B. gurinii, 353; 
B. buvgdovfevi sensu stricto, 283; and B. afzelii, 291. 
Scores for patient DA included in this group were: 
B. gurinii, 11; B. buvgdorferi sensu stricto, 8; and B. afzelii, 
7. Scores for the control group (20 patients with EM) 
were: B. guvinii, 155; B. buvgdovferi sensu stricto, 143; 
and B. afielii, 162. Median scores are shown for 
comparison in Figure 5. In the group of patients with 
neuroborreliosis, the differences between the scores 
of B. garinii and B. buvgdorferi sensu stricto, as well as 
B. gurtnii and B. ujielii, are statistically significant 
Figure 5 Mean SCOICS for each Borrelia species in the group of patients with neuroborreliosis (Neurobor) and with erythema 
migrans (EM). Differences between the scores of B. gurinii and B. buugdo$eri sensu stricto (p<0.001) and B. afielii ($0.005) 
are significant for the neuroborreliosis group and are not significant for the control group (EM). 
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(p<0.001 and p<O.005, respectively), whereas they are 
not significant in the control group. The criterion of 
total score equal or greater than 2 for one particular 
species allowed us to type the serologic reactions of 
patients with neuroborreliosis as follows: 18 B. gavinii; 
three B. b i q d o f e r i  sensu stricto; two B. ufielii; and five 
inconclusive. In the control group, six reactions were 
typed as B. p r i n i i ,  one as B. h u p h j %  serisu stricto, and 
five as B. ufielii and eight were inconclusive (Table 2). 
Minor discrepancies were observed between the two 
readers, particularly with sera having a borderline 
score. For example, in the neuroborreliosis group, one 
inconclusive was grouped as B. garinii by the other 
reader, and one B. p r i n i i  plus one B. burgdo@ sensu 
stricto were found inconclusive by the other reader. 
The mean scores were also very close for the two 
readers; in the neuroborreliosis group, mean scores 
were B. gavinii 12.7 and 12.5, B. burpfovft.ri sensu stricto 
10.0 and 10.2, and B. afrelii 10.3 and 10.5, respectively. 
The comparison of relative incidences of Borrelia 
species showed a significant difference in favor of 
B. pv in i i  in the neuroborreliosis group (p<0.02). O n  
the contrary, there was a significant diffixence in favor 
of B. afielii in the group EM (p<0.01), allowing us to 
observe the relative incidence of infecting Borvelia 
species in the early stage of the disease in our region. 
DISCUSSION 
Borvelia bacteria were cultured from three of 34 CSF 
samples from children in whom Lyme borreliosis was 
suspected. The three isolates were typed as B. gavinii by 
phenotypic and genotypic analysis. Serum from one of 
these three patients, with more proloniged neurologic 
disease and intrathecal antibody synthesis, clearly 
reacted more strongly towards B. garinii (score 11 points) 
than towards B. brrgdoferi sensu stricto (8 points) or B. 
azzelii (7 points) in inimunoblot assays. Additionally, 17 
sera out of 27 other sera from patients with neuro- 
borreliosis confirmed by intrathecal antibody synthesis 
demonstrated a predominant reaction to B. gavinii. 
The association between B. garinii and neuro- 
borreliosis in Europe has been described in few reports 
and always with a small number of isolates [10,19,20]. 
In 1990, Karlson et a1 [lo] suggested that isolates 
with a particular OspA profile were responsible for 
neuroborreliosis in Europe. Although this is the only 
typing information available for the four Swedish 
isolates discussed, their protein profiles indicate that 
they are B. gavinii isolates. Other reports of genotypic 
and phenotypic analysis have not clearly shown the B. 
gnrinii-neuroborreliosis association, as they included 
only a selection of CSF isolates [28-301. However, they 
added important data showing that all three Borrelia 
species may be isolated from the CSF. Busch et a1 [9] 
confirmed on a large panel of 36 CSF isolates that 
all three species were present, but with a clear pre- 
dominance of B. garinii (58%). 
By serologic analysis, others confirmed that B. 
gavinii was more frequently associated with neuro- 
borreliosis in Europe than any other Bovrelia species. 
Assous et a1 [ l X ]  were the first to propose this associa- 
tion on the basis of Western blot. They observed a 
percentage of 46.6% (7/15) of patients with neuro- 
borreliosis who had a stronger reaction to B. pyinii. 
This moderate percentage may reflect a difference 
between patients with early and late neuroborreliosis. 
Indeed, we observed in our three patients that only 
the one with prolonged neurological disease and 
intrathecal antibody synthesis developed a specific anti- 
body response to B. garinii. This assumption motivated 
our selection of patients with neuroborreliosis and 
intrathecal antibody synthesis. In another study, 
Anthonissen et a1 [31] used a very efficient but time- 
consuming method of Western blot of each Bovvelia 
species, testing for residual reactivity after absorption of 
sera with antigens of representative genospecies. Their 
18 Belgian patients with neuroborreliosis showed pre- 
ferential reactivity to B. garinii. 
The prevalence of Borrelia species in one particular 
geographic area may represent a selection bias for their 
relative recognition in association with a particular 
symptom. We have chosen to compare the serologic 
status of patients with early infection (EM) with that of 
a group of patients from the same area with late 
neurologic symptoms. 
The scores applied in the present study were siniple 
to achieve and showed a good reproducibility between 
the two readers. They allowed us to determine on a 
semi-quantitative basis the differential reactivities to 
Borvelia species in most patients. We selected a number 
of proteins for the scoring method, on the basis of 
high inimunogenicity, such as flagellin or OspC, and 
five other high-, medium- and low-molecular-weight 
proteins. Some of these proteins appeared to better 
differentiate the specific serologic reaction, in particular 
the 18-kDa, OspC, p39 and 93-kDa (pl00) proteins in 
our group of patients with neuroborreliosis. The 
comparison of relative incidences of infections probably 
due to one particular Borrelia species showed a signi- 
ficant difference, with the group of patients with 
neuroborreliosis favoring B. p i n i i  (p<0.02) and the 
control group favoring B. qfzelii (y<O.OI). Total 
scores and differences in the control group were less 
important, since the serologic reaction of patients 
with EM was restricted to fewer proteins, particularly 
flagellin, OspC and 18 kDa. In fact, the scores as 
presented seem more useful for quantifying the 
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serologic reaction of patients with late Lyme borreliosis, 
since the number of reactive proteins is larger and 
allows a better total score differentiation. We have 
found a similar, and even better, association of B. ajizelii 
and acrodermatitis chronica atrophicans. Out  of 30 
patients’ sera, 28 (93%) were more reactive to B. afielii 
using the same typing method (unpublished). Further- 
more, in a group of patients with arthritis, about 70% 
showed a stronger reactivity to B. lrurgdovferi sensu 
stricto. This study is in progress and includes the fourth 
Borrelia species (group VS 116) present in the area. So 
far, serology has been an essential tool for the diagnosis 
of Lyme borreliosis, mainly in the late stages, but 
its usefulness is less in endemic areas because of high 
seroprevalence in the population. When conclusive 
data are available on the organotropism of the Borrelia 
species, typing of antibody reactions to the three Borrelia 
species by immunoblot or by other serologic tests will 
be of great interest and will provide further information 
for the definite diagnosis of late Lyme borreliosis. 
In the literature there is more and more evidence 
that clinical manifestations such as arthritis, neurologic 
symptoms and acroderniatitis chronica atrophicans are 
increasingly associated with B. burgdorferi sensu stricto, 
B. garinii and B. afielii respectively [18-20,28,29,31]. 
These differences of association between Borrelia species 
and clinical manifestations may reflect a particular 
tropism of each Borrelia species for a tissue or organ. 
The mechanism of such tropism remains to be investi- 
gated. In addition, a fourth genospecies of Borrelia, 
called group VS 116 [23,24] occurs in ticks of the area 
under study as well as in Europe [32]. Up to now, strains 
belonging to this group have never been isolated from 
humans. However, these strains may also be more 
difficult to grow from patient material. With regard 
to the possible role of this genomic group in Lyme 
borreliosis, we are investigating this issue, using the 
same immunoblots, including this fourth species, with 
sera from patients having defined manifestations of 
Lyme borreliosis. 
Culture is not recommended for routine diagnosis 
of Lyme borreliosis [33] but the isolation of Borrelia 
species from CSF may be very useful for the diagnosis 
of neuroborreliosis, since a weak serologic response is 
sometimes obtained from patients with early neuro- 
logic symptoms. In this regard, P C R  may become an 
essential tool for the early diagnosis and typing of the 
causative agent in the future [32,34]. 
In conclusion, typing of these three CSF isolates 
and characterization by immunoblot of the antibody 
reactions of patients provide additional evidence of the 
association between B. garinii and neuroborreliosis. 
Our serologic results suggest that B. burgdorferi sensu 
stricto and B. afielii are also responsible for some 
neuroborreliosis cases in Switzerland. 
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